Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet [Diovan HCT] — RxCUI 809030
RxNorm drug concept · Semantic branded drug
RxCUI 809030
Semantic branded drug · SBD
● Current RxNorm concept 5 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI809030
Official nameHydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet [Diovan HCT]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDiovan HCT 320/25 Oral Tablet; Diovan HCT 320 MG / 25 MG Oral Tablet; Diovan HCT 320/25 (valsartan / HCTZ) Oral Tablet; HCTZ 25 MG / valsartan 320 MG Oral Tablet [Diovan HCT]
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)92 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Valsartan and Hydrochlorothiazide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This tablet combines two different blood pressure-lowering medicines in one pill: valsartan, which relaxes your blood vessels, and hydrochlorothiazide, a water pill that helps your...
- What exactly is this medication and why did my doctor prescribe it?
- You can take it either way — with or without food. The hydrochlorothiazide part isn't affected by food at all. Food does reduce how much valsartan your body absorbs, but since you...
- Does it matter if I take it with food or on an empty stomach?
🕸️ Concept Web — How Hydrochlorothiazide 25 MG / valsartan 320 MG Ora... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet [Diovan HCT]
RxCUI 809030 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Hydrochlorothiazide
5487IN -
Valsartan
69749IN -
Hydrochlorothiazide / valsartan
214626MIN
-
Hydrochlorothiazide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Diovan HCT
216653BN
-
Diovan HCT
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Hydrochlorothiazide / valsartan Oral Tablet
374280SCDF -
Hydrochlorothiazide / valsartan Oral Product
1162783SCDG -
Hydrochlorothiazide / valsartan Pill
1162784SCDG -
Hydrochlorothiazide / valsartan Oral Tablet [Diovan HCT]
809029SBDF -
Diovan HCT Oral Product
1171082SBDG -
Diovan HCT Pill
1171087SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Hydrochlorothiazide / valsartan Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet
636045SCD -
Hydrochlorothiazide 25 MG
316049SCDC -
Valsartan 320 MG
350561SCDC -
Hydrochlorothiazide 25 MG / valsartan 320 MG [Diovan HCT]
809028SBDC
-
Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet
SCD · 636045 -
Hydrochlorothiazide 25 MG
SCDC · 316049 -
Valsartan 320 MG
SCDC · 350561 -
Hydrochlorothiazide / valsartan Oral Tablet
SCDF · 374280 -
Hydrochlorothiazide / valsartan Oral Product
SCDG · 1162783 -
Hydrochlorothiazide / valsartan Pill
SCDG · 1162784
Brand-Name Concepts
-
Hydrochlorothiazide 25 MG / valsartan 320 MG [Diovan HCT]
SBDC · 809028 -
Hydrochlorothiazide / valsartan Oral Tablet [Diovan HCT]
SBDF · 809029 -
Diovan HCT Oral Product
SBDG · 1171082 -
Diovan HCT Pill
SBDG · 1171087 -
Diovan HCT
BN · 216653
📦 FDA Products & Package NDCs
5 products · 5 package NDCs
5 package NDCs map to RxCUI 809030 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00078-0314-34 | 90 TABLET, FILM COATED in 1 BOTTLE (0078-0314-34) | Diovan HCT | Novartis Pharmaceuticals Corporation | 1998-03-06 |
| 00078-0315-34 | 90 TABLET, FILM COATED in 1 BOTTLE (0078-0315-34) | Diovan HCT | Novartis Pharmaceuticals Corporation | 1998-03-06 |
| 00078-0383-34 | 90 TABLET, FILM COATED in 1 BOTTLE (0078-0383-34) | Diovan HCT | Novartis Pharmaceuticals Corporation | 1998-03-06 |
| 00078-0471-34 | 90 TABLET, FILM COATED in 1 BOTTLE (0078-0471-34) | Diovan HCT | Novartis Pharmaceuticals Corporation | 2006-04-28 |
| 00078-0472-34 | 90 TABLET, FILM COATED in 1 BOTTLE (0078-0472-34) | Diovan HCT | Novartis Pharmaceuticals Corporation | 2006-04-28 |
Observed labelers:
Novartis Pharmaceuticals Corporation (5)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.